News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
Beware: Data Leak Alert in the Most Commonly Used Wallet Among Cryptocurrency Users
BitcoinSistemi·2026/01/05 18:51
Ethereum Layer-2 Network Starknet Back Online Following Outage
Decrypt·2026/01/05 18:42
ICP Trades Near $3.08 as $2.99 Support and $3.20 Resistance Shape Price Action
Cryptonewsland·2026/01/05 18:42
Strategy Pads Cash Reserve, Drops Another $116 Million on Bitcoin
Decrypt·2026/01/05 18:24
Best Altcoins to Buy: DeepSnitch AI Surges 112% as Investors Raise Over $1 Million in 2025
BlockchainReporter·2026/01/05 18:21
USD/JPY falls amid weak US manufacturing data, rising Japanese yields
101 finance·2026/01/05 18:12
Ethereum price breaks bullish from triangle at $3,000 on low volume
Crypto.News·2026/01/05 18:09
Bitget Introduces Gold Trading, Accessible with $USDT
BlockchainReporter·2026/01/05 17:51
CryptoAppsy Maximizes Your Cryptocurrency Management with Real-time Insights
Cointurk·2026/01/05 17:51
Flash
12:56
Spot Gold Drops $14 in Short-Term Spot gold has fallen $14 in the short term, declining over 1.00% during the day, currently reported at $4133.10 per ounce. (Jin Shi)
12:52
Splash Beverage Group Inc. has successfully secured a $1 million strategic investment from C/M Capital Partners.This funding will be specifically allocated for the development of its Cannepil project.
12:51
Vivos (OTC market code: RDGL) has received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) and will initiate a human clinical feasibility study of its Radiogel® Precision Radionuclide Therapy™.This approval marks a key step forward for the clinical application of this innovative therapy, allowing the company to begin initial safety and feasibility assessments in humans. The Radiogel® technology is designed to enable precise radiation treatment within tumors and is expected to provide a new treatment option for cancer patients. The approved clinical study will collect essential data to lay the foundation for larger-scale clinical trials in the future.